SRDX News and Press, Surmodics Inc. From 05/09/23

2023-05-09 03:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-04-29 11:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-04-26 12:24:02 ET Surmodics, Inc (SRDX) Q2 2023 Results Conference Call April 26, 2022 08:00 AM ET Company Participants Gary Maharaj - President and Chief Executive Officer Timothy Arens - Chief Financial Officer Conference Call Participants Brooks O...

2023-04-26 07:05:59 ET Surmodics press release ( NASDAQ: SRDX ): Q2 Non-GAAP EPS of -$0.40 beats by $0.11 . Revenue of $27.2M (+4.2% Y/Y) beats by $1.34M . Medical Device revenue increased $1.3 million, or 7%, to $19.7 million, compared to $18.5 million in the ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31, 2023, and updated its financial guidance for its fiscal year ending September 30, 2023. ...

Registry to enroll up to 500 patients at up to 30 sites, collecting real-world outcomes data for the Pounce ™ Thrombectomy System Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced enrollment of the first...

2023-04-19 19:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Earnings Conference Call and Webcast Will Begin at 7:00 a.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2023 financial results will be relea...

Sublime Radial Access Platform to include the industry’s first suite of torqueable peripheral microcatheters, designed for navigating tortuosity and crossing complex lesions and available for both transradial and transfemoral procedures Surmodics, Inc. (NASDAQ:SRDX), a leading pr...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the 22nd Annual Needham Virtual Healthcare Conference, which is being held from April 17-20, 2023. Management w...